IRADIMED CORP (IRMD) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, IRADIMED CORP's filing signal continuing positive.

IRadimed Corporation is a leading developer, manufacturer, and distributor of MRI-compatible medical devices, uniquely positioned as the sole provider of non-magnetic IV infusion pump systems designed for safe operation within powerful magnetic fields. Its patented MRidium(R) infusion pump systems, including the newer MRidium 3870, and the 3880 MRI-compatible patient vital signs monitoring system, are engineered with non-magnetic components and ultrasonic motors to ensure patient safety and uninterrupted care during MRI procedures. The company primarily serves hospitals and acute care facilities in the United States through a direct sales force of 29 representatives and internationally in approximately 80 countries via independent distributors. Revenue is generated from device sales, extended maintenance agreements, services, and disposable products, with 2025 revenue reaching $83.8 million.

Revenue is primarily driven by the sale of MRI-compatible medical devices, specifically IV infusion pump systems and patient vital signs monitoring systems, along with recurring revenue from extended maintenance agreements, services, and disposable products used with their devices.